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Altered Sexuality and Quality of Life in Female
Hematopoietic Cell Transplant Recipients in The First
Year Following Transplantation
D.Kathryn Tierney. Stanford University Medical Center,
Stanford, California
Topic Signiﬁcance & Study Purpose/Background/
Rationale: Alterations in sexuality following hematopoietic
cell transplantation (HCT) are common and can negatively
impact quality of life (QOL). The etiology of these changes is
the result of cumulative physiological and psychosocial in-
sults beginning with the cancer diagnosis.
Methods, Intervention, & Analysis: Women were surveyed
a four time points, pre-transplant (T1), 2-3 (T2), 6 (T3) and 12
(T4) months post-HCT. Instruments included 1) Menopause-
Speciﬁc Quality of Life Questionnaire, 2) Female Sexual
Function Index and 3) a visual analog scale to measure QOL.
Demographics of the sixty-three participants are shown in
table one. Statistical analyses included t-tests, one-way
repeated measures ANOVA and multiple regression.
Findings & Interpretation: At T4, 51% experienced hot
ﬂashes, 59% decreased sexual desire, 46.9% vaginal dryness
and 49.2% were avoiding intimacy. At T4, 44.9% reported
decreased arousal, 36.7% decreased lubrication, 44.9% difﬁ-
culty experiencing orgasm, 22.4% dyspareunia and 63.3%
reported being dissatisﬁed with the sexual partner at least
half of the time or more. At T4, only 69% of the women had
been sexually active in the past month. There was no sig-
niﬁcant change in mean scores for sexual functioning, sexual
satisfaction and vasomotor symptoms from T1 to T4; indi-
cating no improvement in symptoms. A signiﬁcant decline in
mean scores for physical (p ¼ .011) and psychosocial (p ¼
.019) symptoms was observed over the ﬁrst year indicating a
decrease in symptoms. Mean QOL scores signiﬁcantly
increased (p ¼ .028) in the ﬁrst year, indicating an
improvement in QOL. Multiple linear regression analysis
indicates that 49.2% (adjusted R2 ¼ .492, p ¼ .000) of vari-
ance in QOL scores at T4 is explained by psychosocial and
physical symptoms, sexual satisfaction, QOL score at T1 and
education level. Psychosocial symptoms uniquely explains
21.8% (p ¼ .000), sexual satisfaction 4.58% (p .023) and ed-
ucation level 5.86% (p ¼ .01) of variance in T4 QOL scores.
Discussion & Implications: Nurses can provide anticipatory
guidance on potential changes in sexuality to facilitate
adaptation by reducing the discordance between expecta-
tions and new realities. Based on these ﬁndings, treatment
strategies targeted at decreasing hot ﬂashes, vaginal dryness
and psychosocial symptoms may result in improved QOL.118
Practices and Experiences of Nurses Working on a
Pediatric Bone Marrow Transplant Unit
Caroline Morrison 1, Edith Morris 2. 1 Cincinnati Children’s,
Cincinnati, Ohio; 2 Cincinnati Children’s Hospital Medical
Center, Cincinnati, Ohio
Topic Signiﬁcance & Study Purpose/Background/
Rationale: Bone marrow transplant (BMT) is an intensive
and complex culture. The BMT environment is associated
with multiple stressors for employees that often result in
turnover, burnout, compassion fatigue, anxiety and emotional
exhaustion. Leininger’s Culture Care Diversity and Univer-
sality theory guided this research and has been used to study
organizational culture. The purpose of this study was toexplore the experiences, care meanings, and practices of
nurses working on a pediatric BMT unit. The goal is to provide
meaningful ways to care for nurses working with children
receiving a bone marrow transplant.
Methods, Intervention, & Analysis: This Ethnonursing
study utilized focus groups as a data collection technique to
foster discussion and richness. Data were collected until
saturation was met. Registered nurses recruited from the
unit were grouped as experienced (greater than 2 years
experience, n¼11) or less experienced (less than 2 years
experience, n¼13). Field notes were used to capture context
and observations from group sessions and the care envi-
ronment. Focus group discussions were recorded, tran-
scribed, and coded. Codewordswere identiﬁed from the data
with assistance of NVivo qualitative data analysis software.
Patterns and ﬁnally themes emerged from the data that
explained nursing culture on the BMT unit.
Findings & Interpretation: There were four themes of cul-
ture care for BMT nurses: 1. experiencing stressful situations,
2. growing and developing personally and professionally, 3.
providing trustworthy and respectful care, 4. acquiring
meaningful coping skills. Many stressors identiﬁed by staff
align with the literature such as interprofessional commu-
nication, moral/ethical conﬂict, patient death, and workload.
The majority of coping skills were personal in nature.
Although not generalizable, results may be transferable to
similar populations and environments.
Discussion & Implications: Interventions to promote
healthy, and restructure unhealthy, stress management
techniques and coping skills should be designed and tested
in this population. Interventions aimed at interprofessional
communication and professional development may also be
aid in promoting care.
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A Pilot Study to Examine Sleep in Pediatric Brain Tumor
Patients Hospitalized for High Dose Chemotherapy and
Stem Cell Rescue
Michelle Rickard, Susan Clifton, Troy Wallach,
Belinda Mandress, Margie Kjellin. St. Jude Children’s Research
Hospital, Memphis, Tennessee
Topic Signiﬁcance & Study Purpose/Background/
Rationale: During a 5 day hospitalization of high dose
chemotherapy and stem cell rescue, is sleep quality and
quantity more positive for brain tumor patients ages 4-21
years randomized to a sleep environment intervention
compared to patients randomized to standard of care.
Methods, Intervention, & Analysis: Sleep was assessed
with actigraph and sleep diary. Those randomized to the
intervention arm received “protected sleep time” which
consisted of a minimum of 90 minutes of uninterrupted
sleep, patient room was darkened and hall light “blackened
out” and patients were offered sleep hygiene with white
noise, massage, or bedtime story.
Findings & Interpretation: Eighteen patients were ran-
domized to standard of care and 19 to the interventional arm.
No differences were found in brain tumor site, risk, presence
of VP shunt, gender or age between the groups. Both the
interventional and standard of care had disrupted sleep as
measured by actigraph; however, a statistical difference in
total sleep minutes and wake after sleep onset was found
between brain tumor risk groups. Patients treated as high
risk had poorer sleep quality and quantity.
Discussion & Implications: Patients and parents were
receptive to a sleep intervention during hospitalization, and
those on the intervention arm requested sleep hygiene
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with high dose chemotherapy and stem cell rescue for CNS
tumors have disrupted sleep and thosewith high risk disease
appear to have poorer sleep quality in comparison to average
risk. Poorer sleep quality in high risk patients may be a result
of more extensive surgery, residual tumor and higher doses
of radiation. Lastly, nurses play a role in optimizing the sleep
environment for patients; attention needs to be focused on
sleep interventions for high risk patients undergoing stem
cell transplantation.
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Hear Our Voices: Patient’s Perspective of Financial Impact
of Allogeneic HCT
Mary Weise, Nandita Khera, Pierre Noel. Mayo Clinic Arizona,
Phoenix, Arizona
Topic Signiﬁcance & Study Purpose/Background/
Rationale: Medical science has made great improvement
in Allogeneic Hematopoietic Cell Transplantation (HCT) over
recent decades. Current treatment modalities offer many
recipients curative treatment or increased long-term survi-
vorship. Practice guidelines are working to identify and
improve patient care outcomes and long-term effects of HCT,
offering patients an opportunity to live with their disease
post-transplant. However, the reality is that, for many, sur-
viving HCT offers a mixed blessing. Many practitioners have
identiﬁed frustrations in post-transplant follow-up care
related to the ﬁnancial impact of HCT care. Patients report
devastating impacts upon quality of life (QOL), beyond the
medical concerns of GVHD or other chronic health problems
related to HCT. They report life stressors which may ulti-
mately affect their health and well-being. While much has
been done to offer improved survivorship and quality of care
with HCT, little seems to have been studied regarding the
QOL and ﬁnancial impact of HCT upon post-transplant
survivors.
Methods, Intervention, & Analysis: Data analysis included
qualitative analysis based on a questionnaire which was
mailed to 482 patients (268 respondents¼ 56%) who had
survived allogeneic HCT at the 3 study sites at Mayo Clinic
from 1/06 to 6/12. Questions in the survey were about health
insurance, prescription/medical costs, and employment
which allowed for subjective data on illness and the impact
that HCT has on one’s QOL, physical and emotional well-
being, personal ﬁnances, as well as resource allocation post-
HCT. A section in the questionnaire allowed for patient
comments. This study discusses their open-ended, candid
responses to the impact of transplant. It also allowed for any
thoughts in information that could have helped them better
prepare ﬁnancially for post-transplant care.
Findings & Interpretation: Our sample (n¼268 re-
spondents) reported issues with employment, insurance,
and disability. A majority conveyed an adverse ﬁnancial
impact (>54%) such as a reduction in household income
>50%, need to sell/mortgage home, withdraw money from
savings, and paying more than they could afford for their
medical care. 73% reported that being sick had hurt them
ﬁnancially, with 3% declaring bankruptcy.
Conclusions: A signiﬁcant proportion of post-HCT survivors
report an impact on their personal ﬁnances and QOL, despite
having health insurance coverage. Future research could help
identify at-risk patients, counsel resources, and support in-
terventions which could improve outcomes of HCT.
Discussion & Implications: As transplant practitioners, we
are trying to be advocates of cancer survivorship, yet
consideration of QOL and the ﬁnancial impact of transplantcare should be considered if we are to practice ethically.
Recommendations for correlating QOL studies in HCT, can
help to improve patient outcomes throughout the contin-
uum of care, while helping our patients in what can be life-
long coping with chronic survivorship. Open-ended patient
responses help give practioners a sense of the emotion and
depth of impact as they tell us how transplant affected their
lives. It is important to let patient’s know we are listening, so
that we can open paths for conversation and improve out-
comes.TRANSPLANT NURSING RESEARCH
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Comparing the safety and efﬁcacy of red blood cell
transfusion dose in hematopoietic stem cell transplant
patients: single versus double unit transfusions
Rhonda Evans, Aldijana Avdic, Anne Smith, Sharon Tucker.
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Topic Signiﬁcance & Study Purpose/Background/
Rationale: Until recently, the national standard practice for
blood transfusions in bone marrow transplant patients was
two units of red blood cells (RBCs) per transfusion episode.
This practice was called into question due to safety concerns,
suggesting that one unit of RBCs per transfusion episodemay
be an equivalent or even safer and less costly practice
(assuming factors such as amount of bleeding and hemo-
globin level are equal). Following a thorough review of
existing blood management practices and review of the
literature, our academic medical center changed practice to
routinely transfuse one unit of RBCs per low hemoglobin (7-8
g/dL) episode if certain clinical criteria were met. Following
IRB approval, a retrospective medical record review began to
evaluate this practice change among two groups of hema-
tology-oncology patient populations (allogeneic and autol-
ogous bone marrow transplant). Patient records from these
two groups of patients are being evaluated before and after
the practice change (one vs two units of RBCs/transfusion)
looking at average units of blood products transfused per
patient, impact on length of stay, and estimate of nursing
time costs. The project is expected to generate new knowl-
edge regarding safe blood management practices in hema-
tology oncology patients.
Methods, Intervention, & Analysis: The project is using the
hematology oncology inpatient unit log of admissions and
discharges to identify adult allogeneic and autologous bone
marrow transplant patients who received a blood trans-
fusion for a hemoglobin of 7-8g/dl and hematocrit above
21%; and were not actively bleeding, septic, experiencing a
major infection, or pregnant. Patient data are being obtained
from the University HealthSystem Consortium (UHC) data-
base. 400 cases are being enrolled, 200 from pre-practice
change (7-1-2009 to 6-30-2011) and 200 from post-practice
change (9-1-2011 to 8-31-2013). A two-month gap was
purposefully included between the two time periods to allow
for full transition to the new practice standard of one unit of
RBCs/transfusions. Data thus far suggests a reduction in red
blood cell utilization at an average of 1.3 units per hospital
discharge. Based on these utilization trends, we are esti-
mating a cost savings of at least $1300 per month just in
purchase cost ($200 per RBC unit X 1.3 units per discharge X
an average of 5 patients/month). Additionally, we are esti-
mating a savings in nursing hours of approximately 13 hours
per month (2 hours per RBC transfusion X 1.3 units per
discharge X an average of 5 patients/month).
